emergent logo.jpg
Emergent BioSolutions to Participate in Investor Conferences
05 mai 2021 16h05 HE | Emergent BioSolutions
GAITHERSBURG, Md., May 05, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following...
emergent logo.jpg
Emergent BioSolutions to Participate in Investor Conferences
01 mars 2021 06h30 HE | Emergent BioSolutions
GAITHERSBURG, Md., March 01, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the following...
emergent logo.jpg
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
10 janv. 2021 14h00 HE | Emergent BioSolutions
Expects continued strong financial and operating momentum in 2021, forecasting total revenues of $2 billion at the midpoint and Adjusted EBITDA of $780 million at the midpoint, both increases...
emergent logo.jpg
Emergent BioSolutions to Participate in Investor Conferences
04 janv. 2021 06h30 HE | Emergent BioSolutions
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
TBIO.jpg
Translate Bio to Participate in Upcoming Investor Conferences
29 sept. 2020 16h05 HE | Translate Bio, Inc.
LEXINGTON, Mass., Sept. 29, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
precision_logo.jpg
Precision BioSciences to Present at Upcoming Virtual Investor Conferences in October
28 sept. 2020 07h00 HE | Precision Biosciences
DURHAM, N.C., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage biotechnology company developing allogeneic CAR T and in vivo gene correction therapies...
TBIO.jpg
Translate Bio to Participate in Upcoming Investor Conferences
03 sept. 2020 07h30 HE | Translate Bio, Inc.
LEXINGTON, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative...
jounce.png
Jounce Therapeutics to Participate in Upcoming Virtual Investor Conferences in September
02 sept. 2020 16h01 HE | Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and...
emergent logo.jpg
Emergent BioSolutions to Participate in Virtual Investor Conferences
18 août 2020 06h31 HE | Emergent BioSolutions
GAITHERSBURG, Md., Aug. 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following...
TTM Logo with Tagline 09-06-07.jpg
TTM Technologies, Inc. Announces Upcoming Conference Participation
03 août 2020 16h05 HE | TTM Technologies
SANTA ANA, Calif., Aug. 03, 2020 (GLOBE NEWSWIRE) -- TTM Technologies, Inc. (NASDAQ:TTMI), a leading global printed circuit board (PCB) and radio frequency (“RF”) components manufacturer, today...